Velocity Clinical Research Appoints Ines Abs Country Head of Germany

Velocity Clinical Research, an integrated research site organization, has appointed Ines Abs as its new Country Head of Germany. This reinforces its commitment to growth in Europe at a time when other site networks are retreating from the region.

Her appointment comes as Velocity continues to expand its footprint across Europe, following a series of site acquisitions and operational enhancements.

With a background spanning CROs, academic hospitals, and multinational site networks, Abs is known for her collaborative leadership style and commitment to building high-performing teams. She brings over two decades of experience in clinical research operations, having held senior leadership roles across Germany, South Africa, and Central and Eastern Europe.

Most recently, she served as Director for Central EMEA and South Africa at Synexus, where she oversaw a network of over 10 dedicated and partner sites, and led performance across delivery, quality, revenue, and patient recruitment. 

Abs also played a key role in establishing the European footprint of Symbio Research, a U.S.-based, dermatology-focused CRO, demonstrating her ability to build operational infrastructure and drive growth in new markets.

Abs began her career as a medical assistant before moving into clinical research, with formative roles at GKM Gesellschaft für Therapieforschung and the University Hospital Leipzig. 

Craig Koch, Velocity Executive Vice President, Europe, said, “Germany is one of Europe’s most important clinical research markets, but it’s also one of the most operationally complex. We are proud to be strengthening our leadership team with Ines’s appointment, who brings deep operational expertise, local market knowledge, and a clear track record of building successful, patient-centered site networks. She will play a pivotal role in advancing our growth ambitions in Germany and ensuring excellence across our European network.”